Background	B-O
Oral	B-O
bleeding	B-O
after	B-O
dental	B-O
extraction	B-O
in	B-O
patients	B-O
on	B-O
non-vitamin	B-LF
K	I-LF
oral	I-LF
anticoagulants	B-O
years	B-O
in	B-O
the	B-O
TXA	B-AC
group	B-O
and	B-O
72.7	B-O
.	B-O
No	B-O
patient	B-O
had	B-O
4	B-O
or	B-O
more	B-O
oral	I-LF
bleeds	B-O
in	B-O
the	B-O
TXA	B-AC
group,	B-O
whereas	B-O
10	B-O
patients	B-O
in	B-O
the	B-O
placebo	B-O
group	B-O
had.	B-O
Fig	B-O
3	B-O
shows	B-O
the	B-O
number	B-O
of	I-LF
oral	I-LF
bleeds	B-O
per	B-O
day	B-O
after	B-O
dental	B-O
extraction.	B-O
TXA	B-AC
had	B-O
no	B-O
influence	B-O
on	B-O
early	B-O
post-extraction	B-O
oral	I-LF
bleeding	B-O
had	B-O
an	B-O
unplanned	B-O
medical	B-O
contact	B-O
after	B-O
dental	B-O
extraction	B-O
compared	B-O
to	B-O
patients	B-O
using	B-O
placebo	B-O
patients	B-O
assigned	B-O
to	B-O
TXA	B-AC
and	B-O
77	B-O
bleeds	B-O
in	B-O
24/57	B-O
,	B-O
predominantly	B-O
related	B-O
to	B-O
bleeding.	B-O
Our	B-O
results	B-O
confirm	B-O
the	B-O
high	B-O
event	B-O
rate	B-O
of	I-LF
oral	I-LF
bleeds	B-O
in	B-O
patients	B-O
treated	B-O
with	B-O
NOACs	B-O
undergoing	B-O
tooth	B-O
extraction,	B-O
with	B-O
more	B-O
than	B-O
1	B-O
out	B-O
of	I-LF
4	B-O
patients	B-O
reporting	B-O
any	B-O
bleeding.	B-O
Moreover,	B-O
half	B-O
of	I-LF
the	B-O
patients	B-O
with	B-O
a	B-O
bleeding	B-O
reported	B-O
multiple	B-O
oral	I-LF
bleeding	B-O
events.	B-O
In	B-O
the	B-O
TXA	B-AC
group,	B-O
no	B-O
patients	B-O
had	B-O
4	B-O
or	B-O
more	B-O
bleedings,	B-O
compared	B-O
to	B-O
10	B-O
patients	B-O
in	B-O
the	B-O
placebo	B-O
group.	B-O
Fewer	B-O
patients	B-O
in	B-O
the	B-O
TXA	B-AC
group	B-O
thus	B-O
suffered	B-O
recurrent	B-O
bleeding.	B-O
Two	B-O
patients	B-O
in	B-O
each	B-O
group	B-O
experienced	B-O
allergic	B-O
reactions	B-O
after	B-O
the	B-O
use	B-O
of	I-LF
the	B-O
assigned	B-O
mouthwash,	B-O
and	B-O
no	B-O
patients	B-O
had	B-O
thrombotic	B-O
complications	B-O
after	B-O
the	B-O
use	B-O
of	I-LF
TXA,	B-O
highlighting	B-O
that	B-O
TXA	B-AC
is	B-O
well	B-O
tolerated	B-O
and	B-O
safe	B-O
to	B-O
use.	B-O
The	B-O
intervention	B-O
with	B-O
TXA	B-AC
mouthwash	B-O
is	B-O
also	B-O
affordable,	B-O
readily	B-O
available	B-O
on	B-O
the	B-O
market,	B-O
and	B-O
therefore	B-O
easy	B-O
to	B-O
implement	B-O
in	B-O
clinical	B-O
practice.	B-O
In	B-O
our	B-O
study,	B-O
6	B-O
patients	B-O
in	B-O
the	B-O
TXA	B-AC
group	B-O
and	B-O
9	B-O
patients	B-O
in	B-O
the	B-O
placebo	B-O
group	B-O
interrupted	B-O
their	B-O
NOAC	B-AC
(without	B-O
it	B-O
being	B-O
planned	B-O
in	B-O
preparation	B-O
for	B-O
surgery).	B-O
Unplanned	B-O
interruption	B-O
of	I-LF
anticoagulants	B-O
is	B-O
a	B-O
concern	B-O
in	B-O
clinical	B-O
practice,	B-O
since	B-O
it	B-O
is	B-O
associated	B-O
with	B-O
increased	B-O
risk	B-O
of	I-LF
cardiovascular	B-O
events	B-O
.	B-O
Patient	B-O
adherence	B-O
and	B-O
compliance	B-O
with	B-O
the	B-O
doctor’s	B-O
advice	B-O
remain	B-O
important.	B-O
An	B-O
exploratory	B-O
subgroup	B-O
analysis	B-O
showed	B-O
that	B-O
patients	B-O
who	B-O
underwent	B-O
extraction	B-O
of	I-LF
2	B-O
or	B-O
more	B-O
teeth	B-O
and	B-O
elderly	B-O
patients	B-O
and	B-O
patients	B-O
who	B-O
restarted	B-O
their	B-O
NOAC	B-AC
within	B-O
24	B-O
hours	B-O
after	B-O
the	B-O
dental	B-O
extraction	B-O
might	B-O
benefit	B-O
more	B-O
from	B-O
treatment	B-O
with	B-O
TXA.	B-O
However,	B-O
the	B-O
latter	B-O
finding	B-O
was	B-O
not	B-O
statistically	B-O
significant.	B-O
These	B-O
findings	B-O
support	B-O
the	B-O
hypothesis	B-O
that	B-O
the	B-O
potential	B-O
benefit	B-O
of	I-LF
a	B-O
hemostatic	B-O
agent	B-O
is	B-O
likely	B-O
to	B-O
be	B-O
the	B-O
largest	B-O
in	B-O
patients	B-O
with	B-O
friable	B-O
mucosa	B-O
and	B-O
more	B-O
extensive	B-O
tissue	B-O
damage.	B-O
An	B-O
immature	B-O
coagulum	B-O
combined	B-O
with	B-O
reinitiation	B-O
of	I-LF
the	B-O
anticoagulant	I-LF
may	B-O
then	B-O
result	B-O
in	B-O
bleeding.	B-O
Future	B-O
studies	B-O
may	B-O
focus	B-O
on	B-O
this	B-O
high-risk	B-O
population.	B-O
After	B-O
enrolling	B-O
222	B-O
out	B-O
of	I-LF
236	B-O
planned	B-O
patients,	B-O
the	B-O
trial	B-O
was	B-O
prematurely	B-O
stopped	B-O
during	B-O
the	B-O
SARS-CoV-2	B-AC
pandemic	B-O
after	B-O
a	B-O
futility	B-O
analysis	B-O
by	B-O
the	B-O
Data	B-O
Safety	B-O
Monitoring	B-O
Board	B-O
based	B-O
on	B-O
the	B-O
number	B-O
of	I-LF
patients	B-O
with	B-O
oral	I-LF
bleeding.	B-O
This	B-O
was	B-O
the	B-O
main	B-O
limitation	B-O
of	I-LF
the	B-O
study.	B-O
Another	B-O
limitation	B-O
was	B-O
that	B-O
we	B-O
relied	B-O
on	B-O
self-reported	B-O
information	B-O
gathered	B-O
during	B-O
a	B-O
follow-up	B-O
by	B-O
phone	B-O
to	B-O
assess	B-O
the	B-O
patients’	B-O
compliance	B-O
with	B-O
the	B-O
study	B-O
protocol.	B-O
However,	B-O
the	B-O
studied	B-O
intervention	B-O
was	B-O
a	B-O
simple	B-O
intervention,	B-O
and	B-O
patients	B-O
got	B-O
both	B-O
oral	I-LF
and	B-O
written	B-O
instructions	B-O
on	B-O
a	B-O
schematic	B-O
leaflet	B-O
about	B-O
the	B-O
protocol.	B-O
A	B-O
last	B-O
limitation	B-O
was	B-O
that	B-O
there	B-O
was	B-O
no	B-O
fixed	B-O
time	B-O
point	B-O
on	B-O
restarting	B-O
the	B-O
NOAC	B-AC
after	B-O
dental	B-O
extraction.	B-O
Patients	B-O
were	B-O
instructed	B-O
on	B-O
when	B-O
to	B-O
restart	B-O
their	B-O
NOAC,	B-O
but	B-O
the	B-O
exact	B-O
timing	B-O
of	I-LF
the	B-O
NOAC	B-AC
re-intake	B-O
was	B-O
left	B-O
at	B-O
the	B-O
patient’s	B-O
decision.	B-O
As	B-O
a	B-O
result,	B-O
there	B-O
was	B-O
a	B-O
spread	B-O
in	B-O
the	B-O
timing	B-O
of	I-LF
the	B-O
NOAC	B-AC
restart	B-O
among	B-O
the	B-O
studied	B-O
patients,	B-O
and	B-O
the	B-O
possible	B-O
effect	B-O
hereof	B-O
on	B-O
bleeding	B-O
after	B-O
dental	B-O
extraction	B-O
is	B-O
unclear.	B-O
The	B-O
question	B-O
on	B-O
timing	B-O
of	I-LF
NOAC	B-AC
restart	B-O
needs	B-O
further	B-O
study.	B-O
In	B-O
conclusion,	B-O
a	B-O
10%	B-O
TXA	B-AC
mouthwash	B-O
did	B-O
not	B-O
reduce	B-O
the	B-O
number	B-O
of	I-LF
patients	B-O
with	B-O
any	B-O
oral	I-LF
bleeding	B-O
after	B-O
dental	B-O
extraction,	B-O
nor	B-O
the	B-O
periprocedural	B-O
bleeding	B-O
or	B-O
early	B-O
bleeding	B-O
after	B-O
extraction.	B-O
TXA	B-AC
appears	B-O
to	B-O
reduce	B-O
delayed	B-O
bleeding	B-O
and	B-O
bleeding	B-O
after	B-O
multiple	B-O
dental	B-O
extractions.	B-O
Follow-up	B-O
studies	B-O
may	B-O
explore	B-O
potential	B-O
benefit	B-O
in	B-O
high-risk	B-O
patient	B-O
populations.	B-O
Supporting	B-O
information	B-O
The	B-O
current	B-O
manuscript	B-O
follows	B-O
the	B-O
CONSORT	B-AC
reporting	B-O
guidelines.	B-O
Showing	B-O
1/5:	B-O
pmed.1003601.s001.pdf	B-O
Skip	B-O
to	B-O
fig	B-O
share	B-O
navigation	B-O
1	B-O
/	B-O
5	B-O
Share	B-O
Download	B-O
fig	B-O
share	B-O
S1	B-O
CONSORT	B-AC
Checklist.	B-O
The	B-O
current	B-O
manuscript	B-O
follows	B-O
the	B-O
CONSORT	B-AC
reporting	B-O
guidelines.	B-O
CONSORT,	B-O
Consolidated	B-LF
Standards	I-LF
of	I-LF
Reporting	I-LF
Trials.	B-O
(PDF)	B-O
S1	B-O
SAP	B-O
Interim.	B-O
The	B-O
interim	B-O
statistical	B-O
analysis	B-O
plan	B-O
of	I-LF
the	B-O
EXTRACT-NOAC	B-O
study.	B-O
NOAC,	B-O
non-vitamin	B-LF
K	I-LF
oral	I-LF
anticoagulant.	B-O
(PDF)	B-O
S2	B-O
SAP	B-O
Final.	B-O
The	B-O
final	B-O
statistical	B-O
analysis	B-O
plan	B-O
of	I-LF
the	B-O
EXTRACT-NOAC	B-O
study.	B-O
NOAC,	B-O
non-vitamin	B-LF
K	I-LF
oral	I-LF
anticoagulant.	B-O
(PDF)	B-O
S1	B-O
Table.	B-O
Details	B-O
of	I-LF
the	B-O
dental	B-O
extraction	B-O
are	B-O
given	B-O
according	B-O
to	B-O
the	B-O
treatment	B-O
groups.	B-O
(PDF)	B-O
S2	B-O
Table.	B-O
Details	B-O
of	I-LF
the	B-O
unplanned	B-O
medical	B-O
contacts	B-O
and	B-O
unplanned	B-O
NOAC	B-AC
interruptions	B-O
are	B-O
given	B-O
according	B-O
to	B-O
the	B-O
treatment	B-O
groups.	B-O
NOAC,	B-O
non-vitamin	B-LF
K	I-LF
oral	I-LF
anticoagulant.	B-O
(PDF)	B-O
Acknowledgments	B-O
We	B-O
thank	B-O
study	B-O
coordinator	B-O
Barbara	B-O
Debaveye,	B-O
University	B-O
Hospitals	B-O
of	I-LF
Leuven;	B-O
study	B-O
recruiters	B-O
Laura-Lien	B-O
Poortmans	B-O
and	B-O
Jeroen	B-O
Martens,	B-O
both	B-O
of	I-LF
the	B-O
University	B-O
of	I-LF
Leuven;	B-O
and	B-O
bioinformaticians	B-O
Michiel	B-O
Van	B-O
der	B-O
Haegen	B-O
and	B-O
Ipek	B-O
Guler	B-O
Caamano	B-O
Fajardo,	B-O
University	B-O
of	I-LF
Leuven.	B-O
We	B-O
also	B-O
thank	B-O
Peter	B-O
Van	B-O
Rompaey,	B-O
University	B-O
of	I-LF
Leuven,	B-O
for	B-O
managing	B-O
any	B-O
queries	B-O
in	B-O
the	B-O
database.	B-O
They	B-O
did	B-O
not	B-O
receive	B-O
compensation	B-O
for	B-O
their	B-O
support	B-O
of	I-LF
this	B-O
study.	B-O
